# ğŸ¯ MISSION: BriTROC-1 SERIAL SAE VALIDATION

**Assigned To:** Zo  
**Priority:** ğŸ”´ P0 - IMMEDIATE  
**Status:** âœ… ANALYSIS COMPLETE  
**Last Updated:** 2026-01-26 16:15

## âœ… MISSION COMPLETE

### Key Results:

| Metric | Value |
|--------|-------|
| **Best signature** | CN_s7 at Relapse |
| **AUROC** | **0.874** (95% CI: 0.750-0.974) |
| **p-value** | **0.035** âœ… (Wilcoxon) |
| **Improvement over diagnosis** | +0.180 |

### Serial SAE Hypothesis: âœ… SUPPORTED

- s7 at **Relapse** (0.874) > s7 at **Diagnosis** (0.694)
- Higher post-treatment s7 â†’ more likely platinum resistant

### Caveats:
- Only n=3 resistant vs n=37 sensitive (underpowered)
- OS correlation not significant
- Needs external validation

---

## ğŸ¯ THE OBJECTIVE

Validate Serial SAE hypothesis on **n=182 paired patients** from BriTROC-1:
> "Post-treatment pathway scores predict platinum resistance better than baseline"

---

## ğŸ“Š DATA INVENTORY

### âœ… ACQUIRED

| Data | Source | Status | Path |
|------|--------|--------|------|
| Shallow WGS BAMs (679) | EGA EGAD00001011049 | âœ… Access granted | `outbox.ega-archive.org` |
| Sample metadata | EGA | âœ… Parsed | `data/britoc/OC/EDAG/EGAD00001011049-metadata (1)/samples.json` |
| Clinical response data | Nature Comms Supp | âœ… Downloaded | `data/britoc/OC/41467_2023_39867_MOESM4_ESM.txt` |
| Source data (figures) | Nature Comms Supp | âœ… Downloaded | `data/britoc/OC/source_data/` |

### ğŸ“Š KEY STATS

| Metric | Value |
|--------|-------|
| Total samples | 679 |
| Unique patients | 265 |
| **Paired patients (diagnosis + relapse)** | **182** ğŸ¯ |
| Total data size | 511 GB |

### ğŸ“‹ CLINICAL DATA FIELDS (MOESM4_ESM.txt)

| Field | Use |
|-------|-----|
| `fk_britroc_number` | Patient ID (links to `subject_id` in samples.json) |
| `chemotherapy_line` | Treatment line |
| `overall_response` | CR/PR/SD/PD |
| `progression_date` | For PFI calculation |

---

## ğŸ“‹ EXECUTION PLAN

### Phase 1: Data Linkage â³ IN PROGRESS

- [x] Download EGA metadata
- [x] Parse samples.json to extract patient IDs
- [x] Download clinical supplementary data
- [ ] **Link patient IDs to sample IDs**
- [ ] Create unified patient table with:
  - Sample IDs (diagnosis + relapse)
  - Response at each treatment line
  - Progression dates
  - PFI calculation

### Phase 2: ETL Pipeline Setup

- [ ] Set up Modal secrets for EGA credentials
- [ ] Test SFTP download of 1 sample
- [ ] Build ichorCNA pipeline for shallow WGS
- [ ] Test CNV â†’ pathway score computation

### Phase 3: Batch Processing

- [ ] Process all 679 BAMs (or prioritize 182 paired)
- [ ] Compute DDR/PI3K/VEGF pathway scores
- [ ] Store results in structured format

### Phase 4: Analysis

- [ ] Correlate post-treatment scores with PFI
- [ ] Compute delta (post - pre) correlation
- [ ] 5-fold CV with bootstrap CI
- [ ] Compare to GSE165897 (n=11) results

### Phase 5: Manuscript Update

- [ ] Update Serial SAE manuscript with n=182 validation
- [ ] Create figures
- [ ] Revise statistical methods

---

## ğŸ”§ TECHNICAL DETAILS

### Patient ID Linkage

```
EGA samples.json:  subject_id = "1", "55", "57", ...
Clinical data:     fk_britroc_number = 1, 55, 57, ...
```

**Linkage key:** `subject_id == fk_britroc_number`

### Sample Types

| Title in EGA | Meaning |
|--------------|---------|
| "diagnosis tumour DNA" | Pre-treatment sample |
| "relapse tumour DNA" | Post-treatment sample |

### Pathway Genes (from shallow WGS CNV)

```python
DDR_GENES = ['BRCA1', 'BRCA2', 'PALB2', 'RAD51', 'ATM', 'ATR', 
             'CHEK1', 'CHEK2', 'TP53', 'XRCC1', 'PARP1']
PI3K_GENES = ['PIK3CA', 'PIK3CB', 'AKT1', 'AKT2', 'PTEN', 'MTOR']
VEGF_GENES = ['VEGFA', 'VEGFB', 'KDR', 'FLT1', 'ANGPT1', 'ANGPT2']
```

---

## ğŸ“ FILE LOCATIONS

```
/oncology-coPilot/oncology-backend-minimal/data/britoc/OC/
â”œâ”€â”€ EDAG/EGAD00001011049-metadata (1)/
â”‚   â”œâ”€â”€ samples.json           # 679 samples with patient IDs
â”‚   â”œâ”€â”€ sample_file.json       # Sample â†’ file mapping
â”‚   â”œâ”€â”€ experiments.json       # Experiment metadata
â”‚   â””â”€â”€ ...
â”œâ”€â”€ 41467_2023_39867_MOESM4_ESM.txt   # Clinical response data
â”œâ”€â”€ 41467_2023_39867_MOESM5_ESM.txt   # Additional clinical data
â”œâ”€â”€ 41467_2023_39867_MOESM1_ESM.pdf   # Supplementary PDF
â”œâ”€â”€ source_data/              # Figure source data (76 files)
â”‚   â”œâ”€â”€ figure_1B_layer_1.tsv
â”‚   â””â”€â”€ ...
â””â”€â”€ BriTROC1_METADATA_ANALYSIS.md     # Our analysis summary

/oncology-coPilot/oncology-backend-minimal/pipelines/
â””â”€â”€ britroC_etl.py              # Modal ETL pipeline (draft)

/publications/
â”œâ”€â”€ DATA_ACQUISITION_STRATEGY.md
â””â”€â”€ DATA_ACCESS_REQUESTS.md
```

---

## ğŸ¯ SUCCESS CRITERIA

| Metric | Target | Notes |
|--------|--------|-------|
| Post-treatment DDR correlation with PFI | Ï < -0.5 | Inverse correlation |
| Post-treatment AUROC for resistance | > 0.70 | On held-out data |
| Sample size | n â‰¥ 100 paired | Must be 10x GSE165897 |
| 95% CI width | < 0.15 | Reasonable precision |

---

## â° TIMELINE

| Date | Milestone |
|------|-----------|
| 2026-01-26 | âœ… Clinical data acquired, metadata parsed |
| 2026-01-27 | Complete patient linkage, create unified table |
| 2026-01-28 | Test ETL on 5 samples |
| 2026-01-29 | Start batch processing |
| 2026-01-31 | Complete CNV analysis for paired samples |
| 2026-02-02 | Complete statistical analysis |
| 2026-02-05 | Update manuscript draft |

---

## ğŸ’€ BLOCKERS & RISKS

| Risk | Mitigation |
|------|------------|
| EGA download slow | Use Modal with GCS intermediate storage |
| ichorCNA fails on shallow WGS | Test coverage thresholds, may need alternative |
| Patient ID mismatch | Verify linkage on 10 samples first |
| Missing clinical data for some patients | Document exclusions |

---

## ğŸ“ NOTES

- BriTROC-1 paper: PMID 37474499, DOI: 10.1038/s41467-023-39867-7
- 15 UK centers, recruited 2013-2017
- 209 platinum-sensitive, 67 platinum-resistant at enrollment
- Published finding: "HGSC genome is remarkably stable between diagnosis and relapse"
  - This is interesting! Our Serial SAE hypothesis may contradict this if pathway scores DO change

---

## ğŸ”— RELATED MISSIONS

- MISSION_JR3_COMPLETE_PATHWAY_RESISTANCE.mdc - Overall resistance validation
- IO Response Prediction - Separate track (GSE206422)
- Timing Engine - Can use BriTROC-1 treatment dates
